Valproic Acid Impacts the Growth of Growth Plate Chondrocytes

Int J Environ Res Public Health. 2020 May 22;17(10):3675. doi: 10.3390/ijerph17103675.

Abstract

A range of bone abnormalities including short stature have been reported to be associated with the use of antiepileptic drugs (AEDs) in children. Exactly how AEDs impact skeletal growth, however, is not clear. In the present study, rat growth plate chondrocytes were cultured to study the effects of AEDs, including valproic acid (VPA), oxcarbazepine (OXA), levetiracetam (LEV), lamotrigine (LTG), and topiramate (TPM) on the skeletal growth. VPA markedly reduced the number of chondrocytes by apoptosiswhile other AEDs had no effect. The apoptosis associated noncleaved and cleaved caspase 3, and caspases were increased by exposure to VPA, which up-regulated cyclooxygenase 2 (COX-2) mRNA and protein levels likely through histone acetylation. The COX-2 inhibitor NS-398 attenuated the effects of VPA up-regulating COX-2 expression and decreased VPA-induced caspase 3 expression. The use of VPA in children should be closely monitored or replaced, where appropriate, by AEDs which do not apparently affect the growth plate chondrocytes.

Keywords: apoptosis; cyclooxygenase 2; growth plate chondrocyte; histone acetylation; valproic acid.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anticonvulsants* / toxicity
  • Cells, Cultured
  • Child
  • Chondrocytes / drug effects
  • Growth Plate* / drug effects
  • Humans
  • Lamotrigine
  • Rats
  • Valproic Acid* / toxicity

Substances

  • Anticonvulsants
  • Valproic Acid
  • Lamotrigine